Table 3.
Rosacea Patients’ Clinical Data and the Corresponding WTP
| Clinical Data | N (%) | Average WTP (USD) | ||
|---|---|---|---|---|
| Case 1 | Case 2 | Case 3 | ||
| Duration of rosacea, year | ||||
| 0–1 | 76 (25.08) | 206.21 | 222.13 | 229.89 |
| 1–5 | 227 (74.92) | 197.79 | 212.07 | 217.02 |
| The degree of satisfaction to prior treatment | ||||
| 0–3 | 65(23.30) | 209.63 | 218.11 | 218.55 |
| 4–6 | 114(40.86) | 194.93 | 213.80 | 221.13 |
| 7–10 | 100(35.84) | 199.32 | 213.81 | 220.48 |
| Previous treatment cost | ||||
| <724.80a | 180(59.41) | 182.39 | 197.81 | 203.40 |
| 724.80–1449.59 | 63(20.79) | 218.59 | 231.24 | 237.00 |
| >1449.59 | 60(19.80) | 227.43 | 242.43 | 247.89 |
| Patients self-rated severity of symptoms | ||||
| 0–3 | 85(28.05) | 189.20 | 217.06 | 221.77 |
| 4–6 | 126(41.59) | 201.19 | 210.94 | 219.06 |
| 7–10 | 92(30.36) | 207.83 | 217.44 | 220.64 |
Notes: aWTP of Previous treatment cost<724.80 is significantly different from the other two groups. There is no significant difference in WTP among other parameters.